Cart
sales@molnova.com
PBT-1033
CAS No. 747408-78-2
PBT-1033 ( PB 1033; PBT-2; PBT1033; PBT2; PBT 1033; PBT 2 )
Catalog No. M24759 CAS No. 747408-78-2
PBT-1033(PBT-2) is a potential neuroprotective agent for the treatment of Alzheimer's disease and Huntington's disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 61 | In Stock |
|
| 5MG | 90 | In Stock |
|
| 10MG | 133 | In Stock |
|
| 25MG | 237 | In Stock |
|
| 50MG | 352 | In Stock |
|
| 100MG | 527 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePBT-1033
-
NoteResearch use only, not for human use.
-
Brief DescriptionPBT-1033(PBT-2) is a potential neuroprotective agent for the treatment of Alzheimer's disease and Huntington's disease.
-
DescriptionPBT-1033(PBT-2) is a potential neuroprotective agent for the treatment of Alzheimer's disease and Huntington's disease.
-
SynonymsPB 1033; PBT-2; PBT1033; PBT2; PBT 1033; PBT 2
-
PathwayOthers
-
TargetOther Targets
-
Recptorothers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number747408-78-2
-
Formula Weight271.1
-
Molecular FormulaC12H12Cl2N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCN(C)Cc1ccc(c(Cl)cc(Cl)c2O)c2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Huntington Study Group Reach2HD Investigators.. Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2015 Jan;14(1):39-47. doi: 10.1016/S1474-4422(14)70262-5. PubMed PMID: 25467848.
molnova catalog
related products
-
Tetrahydrojatrorrhiz...
Corypalmine is a kind of alkaloid from Coptis chinensis and purple chinensis, which has inhibitory effect on the germination of plant pathogenic spores and saprophytic fungi.
-
Cbz-NH-PEG2-CH2COOH
Cbz-NH-PEG2-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
N-Carbethoxy-4-piper...
Aminopyrimidine derivatives, processes for their preparation, compositions containing them and their use as pharmaceuticals.
